LEXICON PHARMACEUTICAL

New Data Relating to Sotagliflozin to be Presented at the American Society of Nephrology (ASN) Kidney Week 2023 Annual Meeting

30 10 2023 16:01:00 提供 Nasdaq GlobeNewswire

Data From Two Studies Demonstrating Positive Financial Impact of INPEFA® (Sotagliflozin) to be Presented at the Academy of Managed Care Pharmacy (AMCP) Nexus 2023 National Meeting

17 10 2023 16:01:00 提供 Nasdaq GlobeNewswire

Data Demonstrating Financial Impact of INPEFA® (Sotagliflozin) to be Presented at the Academy of Managed Care Pharmacy (AMCP) Nexus 2023 National Meeting

11 10 2023 09:00:00 提供 Nasdaq GlobeNewswire

INPEFA® (Sotagliflozin) Receives Preferred Formulary Status With Express Scripts For Medicare Patients

09 10 2023 16:01:00 提供 Nasdaq GlobeNewswire

Tom Garner Joins Lexicon as Senior Vice President and Chief Commercial Officer

09 10 2023 08:00:00 提供 Nasdaq GlobeNewswire

Lexicon to Present Post Hoc Analysis of Scored Clinical Trial at the Heart Failure Society of America (HFSA) Annual Scientific Meeting 2023

28 9 2023 09:00:00 提供 Nasdaq GlobeNewswire

Lexicon to Present Study Results Relating to Sotagliflozin and LX9211 at the 59th Annual Meeting of the European Association for the Study of Diabetes (EASD)

26 9 2023 09:00:00 提供 Nasdaq GlobeNewswire

Lexicon Pharmaceuticals to Participate in the H.C. Wainwright & Co. 25th Annual Global Investment Conference

07 9 2023 16:30:00 提供 Nasdaq GlobeNewswire

Lexicon Announces Series of Presentations Relating to LX9211, Its Investigational Drug for the Treatment of Diabetic Peripheral Neuropathic Pain (DPNP)

07 9 2023 09:00:00 提供 Nasdaq GlobeNewswire

Lexicon to Present Analyses of INPEFA™ (sotagliflozin) Clinical Study Results and Changing Patterns of Heart Failure Diagnoses at the European Society of Cardiology (ESC) Congress 2023

21 8 2023 09:00:00 提供 Nasdaq GlobeNewswire

Published Analysis of Sotagliflozin (INPEFA(TM)) Clinical Data Demonstrates Significant Reductions in the Risk of Hospital Readmissions for Heart Failure

08 8 2023 09:00:01 提供 Nasdaq GlobeNewswire

Lexicon Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Business Update

03 8 2023 16:01:00 提供 Nasdaq GlobeNewswire

Lexicon Pharmaceuticals to Host Second Quarter 2023 Financial Results Conference Call and Webcast on August 3, 2023

28 7 2023 16:01:00 提供 Nasdaq GlobeNewswire

Lexicon Elects Diane E. Sullivan to Board of Directors

28 7 2023 08:00:00 提供 Nasdaq GlobeNewswire

Lexicon Announces Planned Advancement of LX9211 Into Late-Stage Development

23 6 2023 20:45:00 提供 Nasdaq GlobeNewswire

Lexicon to Present Study Results Relating to LX9211 and INPEFA™ (Sotagliflozin) at the American Diabetes Association’s 83rd Scientific Sessions

20 6 2023 08:00:02 提供 Nasdaq GlobeNewswire

UPDATE: Lexicon Announces FDA Approval of INPEFA™ (sotagliflozin) for Treatment of Heart Failure

15 6 2023 17:00:30 提供 Nasdaq GlobeNewswire

Lexicon Pharmaceuticals to Participate in the Jefferies 2023 Global Healthcare Conference

06 6 2023 16:01:00 提供 Nasdaq GlobeNewswire

Lexicon Announces Closing of Public Offering and Concurrent Private Placement, Including Full Exercise of Options to Purchase Additional Shares

05 6 2023 16:01:00 提供 Nasdaq GlobeNewswire

Lexicon Announces Pricing of $125 Million Public Offering and Concurrent Private Placement

01 6 2023 08:00:01 提供 Nasdaq GlobeNewswire